Rallybio reports that it has added Amanda Hayward, PhD and Lisa Sinclair to the Rallybio team.
Dr. Hayward will focus on further building Rallybio’s portfolio and Ms. Sinclair will be focused on new product commercial planning, including diagnostic and patient access approaches to support the portfolio.
These leadership appointments advance Rallybio’s mission to identify and accelerate the development of transformative breakthrough therapies for patients with severe and rare disorders. more